AMIX - Company ID 0001617867
The table below shows Autonomix Medical, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2025 | Q1 2025 | Q2 2024 | Q1 2024 | Q2 2023 |
|---|---|---|---|---|---|
| Operating cash flow | -$2.60M | -$8.26M | -$1.85M | -$6.65M | -$661.00K |
| Capital expenditure | $0.00 | $14.00K | $5.00K | $19.00K | $0.00 |
| Investing cash flow | $0.00 | -$14.00K | -$5.00K | -$19.00K | $0.00 |
| Dividends paid | - | - | - | - | - |
| Stock buybacks | - |
Autonomix Medical, Inc. reported operating cash flow of -$12.28M for fiscal year 2026. That is down 48.7% from -$8.26M in fiscal 2025. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| - |
| Financing cash flow | $2.06M | $8.80M | $0.00 | $14.41M | $2.73M |